secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001493152-25-011557
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 2.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals terminates Diabetinol licensing deal; cancels 1M shares issued to Navy Wharf
--------------------------------------------------------------------------------

- Mutually rescinded March 2025 Master Distribution Agreement for Diabetinol, effective July 30, 2025.
- No material early termination penalties incurred by Mangoceuticals.
- Navy Wharf agreed to cancel all 1,000,000 previously issued restricted shares as consideration.
- Unrelated: warrant holder exercised 198,000 warrants at $1.50, raising $297,000 for the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225011557/0001493152-25-011557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225011557/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer